tiprankstipranks
Immunoprecise Antibodies Ltd. (IPA)
:IPA
US Market

ImmunoPrecise Antibodies (IPA) Cash flow

Compare
255 Followers

ImmunoPrecise Antibodies Cash Flow

IPA's free cash flow for Q2 2025 was C$-2.20M. For the 2025 fiscal year, IPA's free cash flow was decreased by C$15.69M and operating cash flow was C$-2.03M. See a summary of the company’s cash flow.
Cash Flow
Jun 24Jun 23Jun 22Jun 21Jun 20
Operating Cash Flow
C$ -4.25MC$ -19.83MC$ -9.92MC$ -600.00KC$ -1.39M
Investing Cash Flow
C$ -1.56MC$ -1.97MC$ -5.21MC$ -2.46MC$ -1.58M
Financing Cash Flow
C$ 1.02MC$ -621.00KC$ 2.88MC$ 43.38MC$ 174.70K
End Cash Position
C$ 3.54MC$ 8.37MC$ 30.05MC$ 41.84MC$ 2.69M
Free Cash Flow
C$ -5.64MC$ -21.33MC$ -11.18MC$ -2.03MC$ -1.97M
Currency in CAD

ImmunoPrecise Antibodies Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis